Resistance treatment of sparsentan/sparsentan

Sparsentan is a new drug used to treat primary immunoglobulin A nephropathy (IgAN). It mainly blocks the endothelin A receptor (ETA) and angiotensin II type 1 receptor (AT1) pathways to protect glomerular podocytes, reduce proteinuria, lower blood pressure and alleviate kidney damage. However, with the popularity of drug use, sparsentan resistance has gradually become a clinical concern.

The drug resistance mechanism of sparsentane is complex and may involve the interaction of multiple factors such as genetic mutations, increases in drug-metabolizing enzymes, changes in drug transporters, target amplification or overexpression, and bypass metabolic pathways. These mechanisms may lead to changes in the metabolism and distribution of drugs in the body, thereby reducing their efficacy or even causing patients to completely lose response to the drug.

Regarding the drug resistance of sparsentane, it is necessary to use genetic testing and other means to determine whether there are gene mutations or variations related to drug resistance. This helps doctors develop treatment plans for patients, including adjusting drug dosages, changing drug types, or using combined drugs to improve the efficacy of the drug.

During the medication process, the patient's liver and kidney function, electrolyte levels, proteinuria and other indicators are regularly monitored to promptly detect and deal with possible drug side effects and adverse reactions. At the same time, pay attention to changes in the patient's condition, evaluate the efficacy and safety of the drug, and adjust the treatment plan in a timely manner.

In addition, for patients who have developed drug resistance, other therapeutic interventions can be considered. For example, for patients with severely impaired renal function, surgical treatment such as kidney transplantation can be considered; for patients with cardiovascular diseases such as hypertension, antihypertensive treatment can be strengthened to reduce the burden on the kidneys.